BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22995177)

  • 1. STOX1A induces phosphorylation of tau proteins at epitopes hyperphosphorylated in Alzheimer's disease.
    van Abel D; Abdulhamid O; Scheper W; van Dijk M; Oudejans CB
    Neurosci Lett; 2012 Oct; 528(2):104-9. PubMed ID: 22995177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Alzheimer-specific Tau epitope AT100 in apoptotic human fetal astrocytes.
    Ksiezak-Reding H; He D; Gordon-Krajcer W; Kress Y; Lee S; Dickson DW
    Cell Motil Cytoskeleton; 2000 Nov; 47(3):236-52. PubMed ID: 11056524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial and temporal distribution of intracellular free cholesterol in brains of a Niemann-Pick type C mouse model showing hyperphosphorylated tau protein. Implications for Alzheimer's disease.
    Treiber-Held S; Distl R; Meske V; Albert F; Ohm TG
    J Pathol; 2003 May; 200(1):95-103. PubMed ID: 12692847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease.
    Boche D; Donald J; Love S; Harris S; Neal JW; Holmes C; Nicoll JA
    Acta Neuropathol; 2010 Jul; 120(1):13-20. PubMed ID: 20532897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration.
    Pei JJ; Braak H; Gong CX; Grundke-Iqbal I; Iqbal K; Winblad B; Cowburn RF
    Acta Neuropathol; 2002 Oct; 104(4):369-76. PubMed ID: 12200623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology.
    Maurage CA; Sergeant N; Ruchoux MM; Hauw JJ; Delacourte A
    Acta Neuropathol; 2003 Feb; 105(2):89-97. PubMed ID: 12536218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neighbored phosphorylation sites as PHF-tau specific markers in Alzheimer's disease.
    Singer D; Lehmann J; Hanisch K; Härtig W; Hoffmann R
    Biochem Biophys Res Commun; 2006 Aug; 346(3):819-28. PubMed ID: 16781671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitotic phosphorylation of tau protein in neuronal cell lines resembles phosphorylation in Alzheimer's disease.
    Preuss U; Mandelkow EM
    Eur J Cell Biol; 1998 Jul; 76(3):176-84. PubMed ID: 9716264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phosphorylation of tau and Alzheimer's disease].
    García T; Jay D
    Gac Med Mex; 2004; 140(3):329-33. PubMed ID: 15259345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different tau epitopes define Abeta42-mediated tau insolubility.
    Pennanen L; Götz J
    Biochem Biophys Res Commun; 2005 Dec; 337(4):1097-101. PubMed ID: 16226718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtubule destruction induces tau liberation and its subsequent phosphorylation.
    Miyasaka T; Sato S; Tatebayashi Y; Takashima A
    FEBS Lett; 2010 Jul; 584(14):3227-32. PubMed ID: 20561519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
    Hoffmann R; Lee VM; Leight S; Varga I; Otvos L
    Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains.
    Zhou XW; Li X; Bjorkdahl C; Sjogren MJ; Alafuzoff I; Soininen H; Grundke-Iqbal I; Iqbal K; Winblad B; Pei JJ
    Neurobiol Dis; 2006 Jun; 22(3):657-68. PubMed ID: 16513361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MARKing tau for tangles and toxicity.
    Drewes G
    Trends Biochem Sci; 2004 Oct; 29(10):548-55. PubMed ID: 15450610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.
    Vincent I; Jicha G; Rosado M; Dickson DW
    J Neurosci; 1997 May; 17(10):3588-98. PubMed ID: 9133382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease.
    Huang HC; Jiang ZF
    J Alzheimers Dis; 2009; 16(1):15-27. PubMed ID: 19158417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p44mpk MAP kinase induces Alzheimer type alterations in tau function and in primary hippocampal neurons.
    Lu Q; Soria JP; Wood JG
    J Neurosci Res; 1993 Jul; 35(4):439-44. PubMed ID: 7689658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.